近年来由于正常细胞、感染细胞和病毒之间详细的生化差别已逐步阐明,有选择性的、毒性较低的、作用于病毒特异酶或一定复制阶段的物质正相继出现,尤其在抗疱疹病毒的药物和重组干扰素的制备及临床应用方面更取得可喜的进展。本届会议主要内容集中在无环鸟苷和DNA 重组干扰素的临床应用和评价。此外还包括免疫调节剂,其他抗病毒物质和早期诊断方法等。讨论的病毒病主要有疱疹类、乙型肝炎、乳头瘤和呼吸道病毒感染,本文综合主要内容于下。 In recent years, due to the detailed biochemical differences between normal cells, infected cells and viruses, it has been gradually clarified that selective and less toxic substances that act on viral-specific enzymes or at a certain replication stage are emerging one after another, especially in the anti-herpes simplex virus Of the drug and recombinant interferon preparation and clinical application of more promising progress. The main focus of this session is the clinical application and evaluation of acyclovir and DNA recombinant interferon. In addition, including immunomodulators, other anti-viral substances and early diagnosis methods. The main viral diseases discussed are herpes, hepatitis B, papilloma and respiratory virus infections. The main contents of this article are summarized below.